ali mahmoudi

Dr. ali mahmoudi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
ali mahmoudiali mahmoudi
ali mahmoudi
ABAlexandra E. Butler
Alexandra E. Butler
TJTannaz Jamialahmadi
Tannaz Jamialahmadi
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar

8 August 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
ali mahmoudiali mahmoudi
ali mahmoudi
SAStephen L Atkin
Stephen L Atkin
NNNikita G Nikiforov
Nikita G Nikiforov
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar
Background: Diabetes is an increasingly prevalent global disease caused by the impairment in insulin production or insulin function. Diabetes in the long term causes both microvascular and macrovascular complications that may result in retinopathy, nephropathy, neuropathy, peripheral arterial disease, atherosclerotic cardiovascular disease, and cerebrovascular disease. Considerable effort has been expended looking at the numerous genes and pathways to explain the mechanisms leading to diabetes-related complications. Curcumin is a traditional medicine with several properties such as being antioxidant, anti-inflammatory, anti-cancer, and anti-microbial, which may have utility for treating diabetes complications. This study, based on the system biology approach, aimed to investigate the effect of curcumin on critical genes and pathways related to diabetes. Methods: We first searched interactions of curcumin in three different databases, including STITCH, TTD, and DGIdb. Subsequently, we investigated the critical curated protein targets for diabetes on the OMIM and DisGeNET databases. To find important clustering groups (MCODE) and critical hub genes in the network of diseases, we created a PPI network for all proteins obtained for diabetes with the aid of a string database and Cytoscape software. Next, we investigated the possible interactions of curcumin on diabetes-related genes using Venn diagrams. Furthermore, the impact of curcumin on the top scores of modular clusters was analysed. Finally, we conducted biological process and pathway enrichment analysis using Gene Ontology (GO) and KEGG based on the enrichR web server. Results: We acquired 417 genes associated with diabetes, and their constructed PPI network contained 298 nodes and 1651 edges. Next, the analysis of centralities in the PPI network indicated 15 genes with the highest centralities. Additionally, MCODE analysis identified three modular clusters, which highest score cluster (MCODE 1) comprises 19 nodes and 92 edges with 10.22 scores. Screening curcumin interactions in the databases identified 158 protein targets. A Venn diagram of genes related to diabetes and the protein targets of curcumin showed 35 shared proteins, which observed that curcumin could strongly interact with ten of the hub genes. Moreover, we demonstrated that curcumin has the highest interaction with MCODE1 among all MCODs. Several significant biological pathways in KEGG enrichment associated with 35 shared included the AGE-RAGE signaling pathway in diabetic complications, HIF-1 signaling pathway, PI3K-Akt signaling pathway, TNF signaling, and JAK-STAT signaling pathway. The biological processes of GO analysis were involved with the cellular response to cytokine stimulus, the cytokine-mediated signaling pathway, positive regulation of intracellular signal transduction and cytokine production in the inflammatory response. Conclusion: Curcumin targeted several important genes involved in diabetes, supporting the previous research suggesting that it may have utility as a therapeutic agent in diabetes.

22 March 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
ali mahmoudiali mahmoudi
ali mahmoudi
ABAlexandra E. Butler
Alexandra E. Butler
MMMuhammed Majeed
Muhammed Majeed
Maciej BanachMaciej Banach
Maciej Banach
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder. Defects in function/expression of genes/proteins are critical in initiation/progression of NAFLD. Natural products may modulate these genes/proteins. Curcumin improves steatosis, inflammation, and fibrosis progression. Here, bioinformatic tools, gene–drug and gene-disease databases were utilized to explore targets, interactions, and pathways through which curcumin could impact NAFLD. METHODS: Significant curcumin–protein interaction was identified (high-confidence:0.7) in the STITCH database. Identified proteins were investigated to determine association with NAFLD. gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were analyzed for significantly involved targets (p < 0.01). Specificity of obtained targets with NAFLD was estimated and investigated in Tissue/Cells–gene associations (PanglaoDB Augmented 2021, Mouse Gene Atlas) and Disease–gene association-based EnrichR algorithms (Jensen DISEASES, DisGeNET). RESULTS: Two collections were constructed: 227 protein–curcumin interactions and 95 NAFLD-associated genes. By Venn diagram, 14 significant targets were identified, and their biological pathways evaluated. Based on gene ontology, most targets involved stress and lipid metabolism. KEGG revealed chemical carcinogenesis, the AGE-RAGE signaling pathway in diabetic complications and NAFLD as the most common significant pathways. Specificity to diseases database (EnrichR algorithm) revealed specificity for steatosis/steatohepatitis. CONCLUSION: Curcumin may improve, or inhibit, progression of NAFLD through activation/inhibition of NAFLD-related genes.

25 April 2023 in IET Nanobiotechnology
Verified
Journal Article
Open access
ali mahmoudiali mahmoudi
ali mahmoudi
SSSeyedeh Belin Tavakoly Sany
Seyedeh Belin Tavakoly Sany
MSMarzieh Ahari Salmasi
Marzieh Ahari Salmasi
Ali BakhshiAli Bakhshi
Ali Bakhshi
ABArad Bustan
Arad Bustan
FGFatemeh Gheybi
Fatemeh Gheybi
The outbreak of COVID‐19 disease, the cause of severe acute respiratory syndrome, is considered a worldwide public health concern. Although studies indicated that the virus could spread through respiratory particles or droplets in close contact, current research have revealed that the virus stays viable in aerosols for several hours. Numerous investigations have highlighted the protective role of air purifiers in the management of COVID‐19 transmission, however, there are still some doubts regarding the efficiency and safety of these technologies. According to those observations, using a proper ventilation system can extensively decrease the spread of COVID‐19. However, most of those strategies are currently in the experimental stages. This review aimed at summarising the safety and effectiveness of the recent approaches in this field including using nanofibres that prevent the spread of airborne viruses like SARS‐CoV‐2. Here, the efficacy of controlling COVID‐19 by means of combining multiple strategies is comprehensively discussed.

24 November 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
MJMohammad Javad Javid-Naderi
Mohammad Javad Javid-Naderi
ali mahmoudiali mahmoudi
ali mahmoudi
PKPrashant Kesharwani
Prashant Kesharwani
TJTannaz Jamialahmadi
Tannaz Jamialahmadi
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar

1 June 2018 in Plant Gene
Verified
Journal Article
Closed access
IGIsa Ghaderi
Isa Ghaderi
MSMohammad Mehdi Sohani
Mohammad Mehdi Sohani
ali mahmoudiali mahmoudi
ali mahmoudi